|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
20,535 |
$2,542,643.70 |
8.39% |
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
9,751 |
$2,422,440.93 |
7.99% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
36,614 |
$2,283,615.18 |
7.53% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
69,767 |
$1,929,057.55 |
6.36% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
8,210 |
$1,905,376.80 |
6.29% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
5,805 |
$1,330,680.15 |
4.39% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
1,179 |
$1,240,296.21 |
4.09% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
6,413 |
$1,230,141.66 |
4.06% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
81,869 |
$1,222,304.17 |
4.03% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
3,002 |
$1,165,256.32 |
3.84% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
1,487 |
$1,162,343.29 |
3.84% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
7,631 |
$1,136,637.45 |
3.75% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
2,206 |
$1,096,006.98 |
3.62% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,934 |
$974,542.60 |
3.22% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
4,052 |
$769,961.04 |
2.54% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
5,510 |
$722,361.00 |
2.38% |
| Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
4,296 |
$577,640.16 |
1.91% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
4,358 |
$441,334.66 |
1.46% |
| PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
6,157 |
$419,845.83 |
1.39% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
8,587 |
$378,343.22 |
1.25% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
2,112 |
$376,970.88 |
1.24% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
13,348 |
$352,387.20 |
1.16% |
| Arrowhead Pharmaceuticals, Inc. |
ARWR |
04280A100 |
Biotechnology |
5,325 |
$336,912.75 |
1.11% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
5,035 |
$310,810.55 |
1.03% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
576 |
$260,213.76 |
0.86% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
3,280 |
$228,058.40 |
0.75% |
| Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
2,753 |
$223,405.95 |
0.74% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
16,087 |
$222,161.47 |
0.73% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
7,280 |
$219,128.00 |
0.72% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
796 |
$219,409.44 |
0.72% |
| Protagonist Therapeutics, Inc. |
PTGX |
74366E102 |
Biotechnology |
1,988 |
$183,055.04 |
0.60% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,342 |
$177,479.50 |
0.59% |
| NewAmsterdam Pharma Company N.V. |
NAMS |
N62509109 |
Biotechnology |
4,879 |
$173,009.34 |
0.57% |
| Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,738 |
$163,198.20 |
0.54% |
| BridgeBio Pharma, Inc. |
BBIO |
10806X102 |
Biotechnology |
2,265 |
$150,577.20 |
0.50% |
| Ligand Pharmaceuticals Inc. (Class B) |
LGND |
53220K504 |
Biotechnology |
727 |
$144,171.37 |
0.48% |
| Mirum Pharmaceuticals, Inc. |
MIRM |
604749101 |
Biotechnology |
1,586 |
$146,371.94 |
0.48% |
| Supernus Pharmaceuticals, Inc. |
SUPN |
868459108 |
Pharmaceuticals |
2,601 |
$142,352.73 |
0.47% |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
5,862 |
$135,294.96 |
0.45% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
864 |
$129,021.12 |
0.43% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,835 |
$127,165.50 |
0.42% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
3,999 |
$120,329.91 |
0.40% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
269 |
$116,208.00 |
0.38% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
4,517 |
$110,937.52 |
0.37% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
6,798 |
$105,844.86 |
0.35% |
| Rhythm Pharmaceuticals, Inc. |
RYTM |
76243J105 |
Biotechnology |
1,138 |
$105,526.74 |
0.35% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
260 |
$86,559.20 |
0.29% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
6,406 |
$84,687.32 |
0.28% |
| Tempus AI, Inc. (Class A) |
TEM |
88023B103 |
Biotechnology |
1,547 |
$82,377.75 |
0.27% |
| US Dollar |
$USD |
|
Other |
63,708 |
$63,707.71 |
0.21% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,683 |
$60,083.10 |
0.20% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|